Clinical Trials Logo

Filter by:
NCT ID: NCT05832294 Recruiting - Recruitment Clinical Trials

Finding a Biomarker for Acute Neuromodulation Effects in Adolescent Depression

Start date: April 20, 2023
Phase: N/A
Study type: Interventional

This pilot study aims to examine the feasibility of recruiting depressed adolescents to examine changes in emotional processing and in neural responses to emotional stimuli after one session of rTMS (which is followed by an open-label phase of 4 weeks active rTMS).

NCT ID: NCT05835869 Recruiting - Carotid Stenosis Clinical Trials

Chorioretinal Vascularization and Electrophysiological Changes After Carotid Revascularization

CAS-AOCT
Start date: April 20, 2023
Phase: N/A
Study type: Interventional

The aim of the study is to evaluate changes in retinal function by means of electro-functional examinations of the retina and to associate them with any changes in chorioretinal vascular density occurring in the ipsilateral eye after carotid revascularization surgery.

NCT ID: NCT05836090 Recruiting - Depressive Symptoms Clinical Trials

Family Spirit Strengths

FSS
Start date: April 20, 2023
Phase: N/A
Study type: Interventional

This project addresses the disproportionate morbidity and mortality associated with mental and behavioral health problems in American Indian and Alaska Native communities. Access to culturally competent and effective behavioral health services is limited in many of these communities. The investigators aim to address this gap by testing the effectiveness of a trans-diagnostic secondary prevention program, Family Spirit Strengths (FSS) that can be embedded within home visiting services. The FSS program is a skills-based program that incorporates elements of evidence-based practice, the Common Elements Treatment Approach (CETA), and materials informed and developed based on an Indigenous advisory group. The FSS program aims to help participants build self-efficacy and coping skills, as well as build stronger connections to others, the participants' community, and cultural resources. The investigators will use a randomized controlled trial, whereby half of the participants will receive FSS and the other half will receive an evidence-based nutrition education program. The investigators' study is grounded in participatory processes and led by a team of Indigenous and allied researchers.

NCT ID: NCT05836792 Recruiting - Knee Osteoarthritis Clinical Trials

The Effect of Cycle Ergometer With Biofeedback on Deep Sensation in Elderly Patients With Knee Osteoarthritis

Start date: April 20, 2023
Phase: N/A
Study type: Interventional

The aim of the randomized controlled study is to investigate the effects of the cycle ergometer with biofeedback on deep sensation in elderly people who has knee osteoarthritis

NCT ID: NCT05838118 Recruiting - CKD Clinical Trials

Washed Microbiota Transplantation (WMT) for Chronic Kidney Disease (CKD)

Start date: April 20, 2023
Phase: N/A
Study type: Interventional

Wahsed microbiota transplantation (WMT) is a novel and promising therapeutic method for Chronic Kidney Disease (CKD). This clinical trail aims to evaluate the efficacy and safety of WMT in the treatment of CKD.

NCT ID: NCT05844644 Recruiting - Type 2 Diabetes Clinical Trials

The Effects of the GOLO for Life® Plan With Release Supplement on Glycemic Control and Weight in Overweight and Obese Adults With Prediabetes or Type 2 Diabetes

Start date: April 20, 2023
Phase: Phase 2
Study type: Interventional

The objective of this study is to investigate the efficacy and safety of the GOLO for Life® Plan (G4LP) and Release supplementation on glycemic control and weight in overweight and obese adults with Prediabetes or Type 2 Diabetes. The change in glycemic control from baseline at Days 90 and 180 following the G4LP and supplementation with Release will be assessed. Additionally, the safety and tolerability of the G4LP and Release supplementation will be measured by the occurrence of and/or changes in pre-emergent and post-emergent adverse events (AEs).

NCT ID: NCT05844670 Recruiting - Pediatric Cancer Clinical Trials

CHildren Treated With Vincristine: A Trial Regarding Pharmacokinetics, DNA And Toxicity of Targeted Therapy In Pediatric Oncology Patients.

CHAPATI
Start date: April 20, 2023
Phase: Phase 4
Study type: Interventional

The goal of this clinical trial is to individualize the dosage of vincristine, a chemotherapy drug, in children with cancer. The main question it aims to answer is: can vincristine dosage be optimized while carefully monitoring toxicity. The following will happen: - Participants will receive vincristine according to the institutional treatment protocol. - After receiving vincristine, blood samples will be taken at three time points. - The amount of vincristine in the blood samples will be determined. - If the amount of vincristine in the blood samples is lower than the reference and the participants do not experience toxicity due to vincristine, the dose of vincristine may be increased. - Toxicity will be carefully monitored.

NCT ID: NCT05850286 Recruiting - Multiple Myeloma Clinical Trials

A Study of VRd-based Regimen Combined With CART-ASCT-CART2 Treatment in NDMM Patients With P53 Abnormalities

Start date: April 20, 2023
Phase: Phase 2
Study type: Interventional

This is a single-arm, open-label study to evaluate the efficacy and safety of VRD(Bortezomib, Lenalidomide and Dexamethasone)-based regimen combined with CART-ASCT-CART2 in patients with newly diagnosed multiple myeloma with p53 gene abnormalities.

NCT ID: NCT05853393 Recruiting - Sleep Clinical Trials

Tween Sleep Patterns, Appetite Control, and Environment

TweenSPACE
Start date: April 20, 2023
Phase:
Study type: Observational

The goal of this study is to learn about how children's sleep is related to their eating behaviors the next day, and to learn about factors that relate to eating behaviors and sleep health that are specific to preadolescent children living in rural communities.

NCT ID: NCT05863234 Recruiting - Clinical trials for Aggressive NK Cell Leukemia

Safety Evaluation Study for Patients With Aggressive NK-cell Leukemia

Start date: April 20, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

This is Phase I/II Dose-Escalation Study to evaluate the tolerability, safety, efficacy and pharmacokinetics of PPMX-T003 in aggressive NK-cell leukemia.